בטמיגה 50 מ"ג - Betmiga 50 mg

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×××××× 25 ×"× - Betmiga 25 mg

×§×××¦× ×¤×¨××§××××××ª (ATC4)

G04BD
Drugs for urinary frequency and incontinence

××¨××× ×¤×¢×× (ATC5)

Mirabegron 50MG âG04BD12

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

××××××ª ××©××¨××¨ ××××©×, TABLETS PROLONGED RELEASE
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Symptomatic treatment of urgency, increased micturition frequency and/or urgency incontinence as may occur in adult patients with overactive bladder (OAB) syndrome

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

01/03/2021

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××ª×¡××× ×ª ×©××¤××××ª ×©×ª× ×¤×¢××× ×××ª×¨ (overactive bladder syndrome)	01/03/2021	×××¨××××××		Overactive bladder

××¡××¨×ª ××××× ××¡×

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 18.06.2019

××××¨× ××¢××× 18.06.2019
××××¨× ××¢××× 01.08.2016
××××¨× ××¢××× 01.11.2015
××××¨× ××¢××× 07.08.2015 (××¡×× Microsoft Word)

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 18.06.2019 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 18.06.2019 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 29.01.2018 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 18.06.2019

×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××××× 50 ×"× ×××××¨ ××©×¨× ×××¨××××ª ×××××× 50 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	ASTELLAS PHARMA EUROPE B.V, THE NETHERLANDS
×©× ××¢× ××¨××©××	ASTELLAS PHARMA INTERNATIONAL B.V., ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 2/2014. ×¨××©××× ××ª××¨××: 01/2017
×ª××¨×× ×¢×××× ×××¨××	14/05/19

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

השינוי האחרון נעשה בֹ־21 ביוני 2021 ב־04:39

בטמיגה 50 מ"ג - Betmiga 50 mg

ויקיתרופות